Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery”

386 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 386 results

Not applicableStudy completedNCT00466271
What this trial is testing

Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study

Who this might be right for
Chronic Hepatitis CHepatic Fibrosis
National Taiwan University Hospital 102
Testing effectiveness (Phase 2)UnknownNCT05821361
What this trial is testing

HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Unrescetable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT06974344
What this trial is testing

Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)

Who this might be right for
Small-for-Size Syndrome
King Faisal Specialist Hospital & Research Center 80
Large-scale testing (Phase 3)Study completedNCT02856126
What this trial is testing

HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Not applicableUnknownNCT05002452
What this trial is testing

Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03856658
What this trial is testing

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Who this might be right for
Pancreatic AdenocarcinomaLiver Metastases
Corewell Health West 14
Not applicableUnknownNCT00522509
What this trial is testing

Preoperative Hepatic Arterial Infusion Chemotherapy

Who this might be right for
Colorectal Liver Metastases
IRCCS San Raffaele
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)UnknownNCT05839197
What this trial is testing

A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC

Who this might be right for
Macrotrabecular Massive Hepatocellular Carcinoma
Wan-Guang Zhang 38
Large-scale testing (Phase 3)Ended earlyNCT03500874
What this trial is testing

Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM

Who this might be right for
Colorectal CancerLiver MetastasesHAI
Sun Yat-sen University 92
Testing effectiveness (Phase 2)Looking for participantsNCT06632717
What this trial is testing

Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 24
Not applicableStudy completedNCT04195438
What this trial is testing

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Who this might be right for
Liver Cancer
University of Maryland, Baltimore 25
Not applicableNot Yet RecruitingNCT06823050
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Who this might be right for
Hepatocellular Carcinoma
Xuhua Duan 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT04251715
What this trial is testing

MFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver and Intrahepatic Bile Duct CarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8+3 more
OHSU Knight Cancer Institute 5
Large-scale testing (Phase 3)Study completedNCT02973685
What this trial is testing

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 315
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Testing effectiveness (Phase 2)UnknownNCT05519410
What this trial is testing

Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

Who this might be right for
Resectable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06143579
What this trial is testing

HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
Potentially Resectable Hepatocellular Carcinoma
Sun Yat-sen University 48
Not applicableUnknownNCT03191123
What this trial is testing

Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor

Who this might be right for
Carcinoma, HepatocellularSurvival Rate
Huazhong University of Science and Technology 100
Not applicableNot Yet RecruitingNCT07031570
What this trial is testing

Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM

Who this might be right for
Colorectal Cancer Metastatic
Peking University Cancer Hospital & Institute 500
Load More Results